AIG
38
2
EOG
32
3
SYK
57
6
MCD
57
5
EQR
37
3
HCA
39
2
CPB
27
5
FE
37
3
WFC
60
2
ETN
65
2
MTB
40
2
FOX
73
3
PNR
60
3
TEL
60
2
TDC
70
2
ADM
27
2
M
48
2
CRM
67
2
COF
52
5
MAR
60
3
AIG
38
2
EOG
32
3
SYK
57
6
MCD
57
5
EQR
37
3
HCA
39
2
CPB
27
5
FE
37
3
WFC
60
2
ETN
65
2
MTB
40
2
FOX
73
3
PNR
60
3
TEL
60
2
TDC
70
2
ADM
27
2
M
48
2
CRM
67
2
COF
52
5
MAR
60
3
Financhill
Back

Bio-Rad Laboratories 10K Form

Sell
47

BIO
Bio-Rad Laboratories

Last Price:
$329.94
Seasonality Move:
8.52%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive BIO News And Ratings

See the #1 stock for the next 7 days that we like better than BIO

BIO Financial Statistics

Sales & Book Value

Annual Sales: $2.7B
Cash Flow: $100M
Price / Cash Flow: 41.99
Annual Sales: $267.46
Price / Book: 1.24

Profitability

EPS (TTM): -27.33000
Net Income (TTM): $-778.7M
Gross Margin: $1.4B
Return on Equity: -9.62%
Return on Assets: -6.82%

Bio-Rad Laboratories Earnings Forecast

Key Bio-Rad Laboratories Financial Ratios

  • The Gross Profit Margin over the past 40 years for BIO is 53.42%.
  • The Selling, General & Administrative Expenses for BIO have been equal to 31.51% of Gross Profit Margin.
  • The Research & Development expenses have been 9.26% of Revenue.
  • The Interest Expense is -7.76% of Operating Income.
  • The Net Earning history of BIO is -23.86% of Total Revenues.
  • Per Share Earnings over the last 40 years have been positive in 26 years.

Bio-Rad Laboratories Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: BIO
CUSIP: 090572
Website: bio-rad.com

Debt

Debt-to-Equity Ratio: 0.16
Current Ratio: 6.14
Quick Ratio: 4.19

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 29.16

BIO Technical Analysis vs Fundamental Analysis

Sell
47
Bio-Rad Laboratories (BIO) is a Sell

Is Bio-Rad Laboratories a Buy or a Sell?